AMR Action Fund GP, LLC
General Information
Identification Code: 859359848269-33
Website: [object Object]
Entity Form: Limited Liability Company
Registration Category: Companies & groups
Registration Date: 12/2/2022
Last Update: 11/28/2023
EP Accredited Number: 0
Mission & Interests
Goals: The AMR Action Fund enables breakthroughs in antimicrobials.
We invest in companies that are developing urgently needed therapeutics for priority pathogens and advocate for market reforms to change how society values these lifesaving drugs. Our aim is to help launch two to four new antimicrobials within the next decade and create a sustainable ecosystem of investment and innovation to take on one of the biggest global health challenges of our generation.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- International co-operation and development
- Public health
- Research and innovation
Levels of Interest:
- global
Activities
Main EU Legislative Proposals: Activities related to antimicrobial development, including incentives for innovation and equitable access, most recently the General Pharmaceutical Legislation Revision.
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: 225 Franklin StreetSuite 1750
City: Boston
Country: UNITED STATES
Phone: [object Object]
EU Office
Address: Messeplatz 10
City: Basel
Country: SWITZERLAND
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Membership Information
Members10 Percent: 2
Members25 Percent: 1
Members50 Percent: 0
Members75 Percent: 0
Members: 3
Members F T E: 0.44999998807907104
Info Members: Two of our employees listed above each devote less than 5% of their working time on the covered activities per year, and the third employee devotes closer to 15% of their working time on the covered activities per year, therefore our FTE calculation is closer to 0.25.
Structure
Structure Type: Structure
Is Member Of: The concept for an investment fund to support companies developing potentially lifesaving antimicrobial therapeutics originated in conversations among the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the World Health Organization, the European Investment Bank, and the Wellcome Trust.
Limited Partners (LPs) provide the funding for AMR Action Fund investments: https://www.amractionfund.com/about
Investment decisions are taken independently of the LPs, under the guidance of a Scientific Advisory Board. Many of the LPs (e.g. pharmaceutical companies) are members of trade associations such as IFPMA and EFPIA.
Organisation Members: The AMR Action Fund is a member of the Swiss Roundtable on Antibiotics: https://roundtableantibiotics.ch/de/about-us
Quadripartite MultiStakeholder Forum